Keyphrases
Clinical Treatment
100%
Sex Differences
100%
Clinical Features
100%
Chronic Migraine
100%
Migraine
37%
Migraineurs
25%
Clinical Characteristics
12%
Divergence
12%
Headache
12%
Estrogen
12%
Workability
12%
Progesterone
12%
Treatment Response
12%
Resting-state Functional Connectivity (rs-FC)
12%
Medical Costs
12%
Male Population
12%
Testosterone
12%
Neuroimaging Studies
12%
Episodic Migraine
12%
Sexually Dimorphic
12%
Economic Burden
12%
Prevalence Estimation
12%
Sex Hormones
12%
Preventive Treatment
12%
Topiramate
12%
Female Population
12%
Headache-related Disability
12%
OnabotulinumtoxinA
12%
Calcitonin Gene-related Peptide Monoclonal Antibody
12%
Medicine and Dentistry
Sex Difference
100%
Pathophysiology
100%
Clinical Feature
100%
Transformed Migraine
100%
Prevalence
37%
Migraine
37%
Headache
25%
Health Care Cost
12%
Population
12%
Monoclonal Antibody
12%
Sex Hormone
12%
Treatment Response
12%
Progesterone
12%
Botulinum Toxin A
12%
Episodic Migraine
12%
Work Capacity
12%
Topiramate
12%
Calcitonin Gene Related Peptide
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Clinical Feature
100%
Transformed Migraine
100%
Prevalence
37%
Migraine
37%
Headache
25%
Monoclonal Antibody
12%
Sex Hormone
12%
Progesterone
12%
Botulinum Toxin A
12%
Topiramate
12%
Calcitonin Gene Related Peptide
12%
Episodic Migraine
12%
Neuroscience
Migraine
100%
Headache
16%
Monoclonal Antibody
8%
Sex Hormone
8%
Progesterone
8%
Calcitonin
8%
Topiramate
8%
Botulinum Toxin A
8%